Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 30.75

-1.8%

Nov 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gerald Thomas who wrote (70)	4/4/1997 8:00:00 PM
From: Douglas	of 455

Dr. Pallai was Procept's director of rational drug design. His name was mentioned in the press release announcing the research alliance with Molecular Simulations Inc. I don't think he was significant in the testing of the PRO 2000 gel. I have noticed that Sonderfan's name was prominant when they discuss topical microbicide. I am curious how you calculated the $10-$15 range. How did you arrive at these numbers? I hope your right.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next